Jason Casell Discusses Qui Tam Actions in the Pharmaceutical Industry

News / July 1, 2011

Counsel Jason Casell co-wrote an article on the use of qui tam actions in the pharmaceutical industry for the July 2011 edition of DRI’s In-House Defense Quarterly. In the article, he discusses what a qui tam action is and how it is used to hold pharmaceutical manufacturers accountable for their products.

Read the article.